BioCentury
ARTICLE | Financial News

Forbion closes third life sciences fund

April 13, 2016 12:22 AM UTC

Forbion Capital Partners closed its third life sciences fund, Forbion Capital Fund III, at EUR 183 million ($208.2 million).

The fund's LPs include the European Investment Fund, Dutch Venture Initiative, KfW, Charles River Laboratories International Inc. (NYSE:CRL), Knight Therapeutics Inc. (TSX:GUD) and undisclosed regional investment agencies, pension funds, insurance companies and European family offices. ...